Chinese Medicine Ordinance (Cap.549)
- Notifying member
- Hong Kong, China
- Title
- Chinese Medicine Ordinance (Cap.549)
- First published
- 06/08/1999
- First EIF
- Latest published
- 28/06/2018
- In force to
- Latest notification
- G/LIC/N/3/HKG/27
- Product categories
- List of products subject to licensing
- Nature of licensing
-
Non-automatic
- Administrative purpose/measure being implemented
-
- Other
- Decription of purpose/measure being implemented
-
The import licensing procedure aims to establish a mechanism to regulate, inter alia, the import of the proprietary Chinese medicines and 36 Chinese herbal medicines into Hong Kong Special Administrative Region. The applicant is required to hold an appropriate trader’s licence issued by the Chinese Medicine Board prior to the application for an import licence. Unless otherwise stated, an import licence is valid for six months.
- Administrative body(ies) for submission of applications
-
- Chinese Medicines Section, Chinese Medicine Division, Department of Health
- 16/F, AIA Kowloon Tower, Landmark East, 100 How Ming Street, Kwun Tong, Kowloon, Hong Kong, China.
- Contact point for information on eligibility
-
Same as the "Administrative bodies"
- Expected duration of licensing procedure
- Two working days after submission of application for the import licence, subject to the availability of sufficient information.
- Found by secretariat
- No
- Related document symbols
-
- G/LIC/N/2/HKG/4
- G/LIC/N/2/HKG/5
- Source
-
The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 16 November 2007. It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the consequential amendment to the Import and Export (General) Regulations, Cap. 60A shall come into operation.
- Notes
-
-
G/LIC/N/2/HKG/4
The Chinese Medicine Ordinance (Commencement) Notice 2007 was gazetted on 16 November 2007. It stipulates 11 January 2008 to be the date on which, among others, the relevant provisions of the Chinese Medicine Ordinance (Cap 549) including the consequential amendment to the Import and Export (General) Regulations, Cap. 60A shall come into operation.
The import licensing procedure aims to establish a mechanism to regulate, inter alia, the import of the proprietary Chinese medicines and 36 Chinese herbal medicines into Hong Kong Special Administrative Region. The applicant is required to hold an appropriate trader’s licence issued by the Chinese Medicine Board prior to the application for an import licence. Unless otherwise stated, an import licence is valid for six months.
-
G/LIC/N/2/HKG/5
Any article specified in Sections 2A, 2B and 2C of Part I of the First Schedule of the Import and Export (General) Regulations, Cap. 60A, which are listed below, are subject to import licensing procedures:
- 31 Chinese herbal medicines specified in Schedule 1 of the Chinese Medicine Ordinance (Cap 549);
- 5 Chinese herbal medicines specified in Schedule 2 of the Chinese Medicine Ordinance (Cap 549), namely, Flos Campsis, Processed Radix Aconiti, Processed Radix Aconiti Kusnezoffii, Radix Clematidis and Radix Gentianae;
- Proprietary Chinese medicines as defined in Section 2 of the Chinese Medicine Ordinance (Cap 549).
-